JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


The Journal of Nuclear Medicine Vol. 5 No. 12 929-935
© 1964 by Society of Nuclear Medicine
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Meckelnburg, R. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Meckelnburg, R. L.

Clinical Value of Generator Produced 87-M Strontium

R. L. Meckelnburg, M. D.1

Wilmington, Delaware

ABSTRACT

The findings of this investigative procedure have shown the usefulness of the yttrium-strontium generator for making a short-lived isotope available to laboratories remote from the production facility. The present technique demonstrates the simplicity of the process required for the use of 87-M strontium in patients. The low radiation exposure makes this particular isotope suitable for study of other nonmalignant conditions, such as fractures, infections and osteopenic states. Even studies in children can be performed without undue exposure. Because of the short half-life, repeat studies of bone metastasis can be made to measure the effectiveness of different forms of therapy. The large doses possible with 87-M strontium improve counting statistics and thereby enhance resolution, gaining better definition and shorter scanning times.

FOOTNOTES

1 Department of Isotopes and Endocrinology, Memorial Hospital, Wilmington, Delaware.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 1964 by the Society of Nuclear Medicine.